Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Genetic Testing Market - Forecast 2026-2032 | AI and Next-Generation Sequencing Drive 14.44% CAGR Toward USD 39.72 Billion

globenewswire.com
ABT Abbott Laboratories is listed as a company profile in a report on the global genetic testing market, indicating its potential involvement or interest in this sector. The article does not provide specific sentiment towards Abbott. AGNC Agilent Technologies, Inc. is mentioned as a company profile within a report on the genetic testing market. The article does not express a specific sentiment towards the company's performance or prospects. BDX Becton, Dickinson and Company is listed in the company profiles section of a genetic testing market report. The article does not offer specific sentiment regarding this company. BIO Bio-Rad Laboratories, Inc. is listed as a company profile in the context of the genetic testing market. The article does not express any particular sentiment towards the company. BTE Bio-Techne Corporation is mentioned in the company profiles section of the genetic testing market report. The article does not contain specific sentiment for this company. BRKR Bruker Corporation is listed as a company profile within the genetic testing market report. The article does not provide any sentiment analysis for Bruker. ILMN Illumina, Inc. is mentioned in the company profiles section of the genetic testing market report. The article does not express specific sentiment towards Illumina. LH Laboratory Corporation of America Holdings is listed in the company profiles of the genetic testing market report. The article does not offer specific sentiment towards the company. MYGN Myriad Genetics, Inc. is mentioned as a company profile in the genetic testing market report. The article does not provide specific sentiment towards Myriad Genetics. NTRA Natera, Inc. is listed as a company profile in the genetic testing market report. The article does not provide specific sentiment towards Natera. QGEN Qiagen N.V. is mentioned in the company profiles section of the genetic testing market report. The article does not express specific sentiment towards Qiagen. DGX Quest Diagnostics Incorporated is listed in the company profiles of the genetic testing market report. The article does not offer specific sentiment towards the company. RVTY Revvity Inc. is listed as a company profile in the genetic testing market report. The article does not provide specific sentiment towards Revvity. TMO Thermo Fisher Scientific Inc. is mentioned in the company profiles section of the genetic testing market report. The article does not express specific sentiment towards Thermo Fisher Scientific.

Global Genetic Testing Market - Forecast 2026-2032 | AI and Next-Generation Sequencing Drive 14.44% CAGR Toward USD 39.72 Billion Dublin, Nov. 19, 2026 (GLOBE NEWSWIRE) -- "Genetic Testing Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.

This market research report analyzes the global genetic testing market, which is projected to reach USD 17.60 billion in 2026 and expand at a CAGR of 14.44% to USD 39.72 billion by 2032. It examines the technologies, clinical applications, regulatory developments, and regional dynamics moving genetic testing from specialized diagnostics into mainstream healthcare. The findings support strategic planning, market-entry assessment, and identification of high-growth opportunities across precision medicine.

Market Growth Drivers

Next-generation sequencing, PCR-based assays, microarrays, and targeted panels are enabling earlier disease detection, carrier screening, pharmacogenomics, oncology companion diagnostics, and personalized treatment selection. Declining sequencing costs are also broadening access across hospitals, reference laboratories, and direct-to-consumer channels.

Demand is reinforced by the growing burden of cancer, rare diseases, inherited cardiovascular conditions, reproductive health needs, and medication-response variability. At the same time, regulators, payers, and health systems are placing greater emphasis on analytical and clinical validity, informed consent, data privacy, and equitable access.

Transformative Market Shifts

These insights allow decision-makers to align product portfolios with clinically validated applications while anticipating reimbursement and compliance risks.

Artificial Intelligence in Genetic Testing

Artificial intelligence is improving variant calling, annotation, phenotype matching, laboratory automation, and clinical report generation. AI-enabled bioinformatics can prioritize variants of uncertain significance, connect genomic findings with curated databases such as ClinVar, and accelerate interpretation in oncology and rare disease testing.

Successful deployment requires explainability, validation across diverse populations, bias monitoring, cybersecurity, expert review, and compliance with privacy frameworks including HIPAA and GDPR.

Regional and Economic Group Insights

Coverage of ASEAN, GCC, EU, BRICS, G7, and NATO markets provides a practical basis for comparing regulatory readiness, infrastructure, investment priorities, and partnership potential.

Strategic Priorities for Market Participants

Key Takeaways from This Report

Key Attributes:

Key Topics Covered:

1. Preface

1.1. Objectives of the Study

1.2. Market Definition

1.3. Market Segmentation & Coverage

1.4. Years Considered for the Study

1.5. Currency Considered for the Study

1.6. Language Considered for the Study

1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction

2.2. Research Design

2.2.1. Primary Research

2.2.2. Secondary Research

2.3. Research Framework

2.3.1. Qualitative Analysis

2.3.2. Quantitative Analysis

2.4. Market Size Estimation

2.4.1. Top-Down Approach

2.4.2. Bottom-Up Approach

2.5. Data Triangulation

2.6. Research Outcomes

2.7. Research Assumptions

2.8. Research Limitations

3. Executive Summary

3.1. Introduction

3.2. CXO Perspective

3.3. New Revenue Opportunities

3.4. Next-Generation Business Models

3.5. Industry Roadmap

4. Market Overview

4.1. Introduction

4.2. Industry Ecosystem & Value Chain Analysis

4.2.1. Supply-Side Analysis

4.2.2. Demand-Side Analysis

4.2.3. Stakeholder Analysis

4.3. Market Dynamics

4.3.1. Key Drivers

4.3.2. Key Restraints

4.3.3. Key Opportunities

4.3.4. Key Challenges

4.4. Porter's Five Forces Analysis

4.5. PESTLE Analysis

4.6. Market Outlook

4.6.1. Near-Term Market Outlook (0-2 Years)

4.6.2. Medium-Term Market Outlook (3-5 Years)

4.6.3. Long-Term Market Outlook (5-10 Years)

4.7. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective

5.2. Consumer Experience Benchmarking

5.3. Opportunity Mapping

5.4. Distribution Channel Analysis

5.5. Pricing Trend Analysis

5.6. Regulatory Compliance & Standards Framework

5.7. ESG & Sustainability Analysis

5.8. Disruption & Risk Scenarios

5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Genetic Testing Market, by Offering

7.1. Introduction

7.2. Instruments

7.2.1. Sequencers

7.2.2. PCR Systems

7.2.3. Microarray Scanners

7.3. Software & Informatics

7.3.1. Variant interpretation

7.3.2. Clinical decision support

7.3.3. Bioinformatics

7.4. Services

7.4.1. Consulting

7.4.2. Maintenance & Support

7.5. Reagents & Consumables

8. Genetic Testing Market, by Test Type

8.1. Introduction

8.2. Carrier Testing

8.3. Diagnostic Testing

8.4. New Born Screening

8.5. Pharmacogenomics

8.6. Preimplantation Testing

8.7. Prenatal Testing

8.8. Presymptomatic & Predictive Testing

9. Genetic Testing Market, by Technology

9.1. Introduction

9.2. Cytogenetics

9.3. DNA Sequencing

9.4. Gene Expression Profiling

9.5. Microarrays

9.6. Polymerase Chain Reaction (PCR)

10. Genetic Testing Market, by Sample Type

10.1. Introduction

10.2. Blood

10.3. Saliva

10.4. Tissue

10.5. Buccal swab

11. Genetic Testing Market, by Application

11.1. Introduction

11.2. Autoimmune Disorders

11.3. Oncology

11.4. Chronic Diseases

11.5. Genetic Disorders

11.6. Neurodegenerative Diseases

12. Genetic Testing Market, by End-User

12.1. Introduction

12.2. Diagnostic Laboratories

12.3. Home Setting

12.4. Hospitals & Clinics

13. Genetic Testing Market, by Distribution Channel

13.1. Introduction

13.2. Offline

13.3. Online

14. Genetic Testing Market, by Region

14.1. Introduction

14.2. Asia-Pacific

14.3. North America

14.4. Latin America

14.5. Europe

14.6. Middle East

14.7. Africa

15. Genetic Testing Market, by Group

15.1. Introduction

15.2. ASEAN

15.3. GCC

15.4. European Union

15.5. BRICS

15.6. G7

15.7. NATO

16. Genetic Testing Market, by Country

16.1. Introduction

16.2. United States

16.3. Canada

16.4. Mexico

16.5. Brazil

16.6. United Kingdom

16.7. Germany

16.8. France

16.9. Russia

16.10. Italy

16.11. Spain

16.12. China

16.13. India

16.14. Japan

16.15. Australia

16.16. South Korea

17. Competitive Landscape

17.1. Market Share Analysis, 2025

17.2. Market Concentration Analysis, 2025

17.2.1. Concentration Ratio (CR)

17.2.2. Herfindahl Hirschman Index (HHI)

17.3. Recent Developments & Impact Analysis, 2025

17.4. Product Portfolio Analysis, 2025

17.5. Benchmarking Analysis, 2025

18. Company Profiles

18.1. Abbott Laboratories

18.2. Agilent Technologies, Inc.

18.3. Becton, Dickinson and Company

18.4. BGI Genomics

18.5. Bio-Rad Laboratories, Inc.

18.6. Bio-Techne Corporation

18.7. Bruker Corporation

18.8. CooperSurgical Inc.

18.9. Eurofins Scientific SE

18.10. F. Hoffmann-La Roche AG

18.11. GeneDx, LLC

18.12. Guardant Health Inc.

18.13. Illumina, Inc.

18.14. Invitae Corporation

18.15. Laboratory Corporation of America Holdings

18.16. Myriad Genetics, Inc.

18.17. Natera, Inc.

18.18. Newtopia Inc.

18.19. PathogenDx Corporation

18.20. PerkinElmer Inc.

18.21. Qiagen N.V.

18.22. Quest Diagnostics Incorporated

18.23. Revvity Inc.

18.24. Sanofi S.A.

18.25. Sonic Healthcare

18.26. Tempus AI, Inc.

18.27. Thermo Fisher Scientific Inc.

19. Key Experts

List of Figures [25]

List of Tables [380]

For more information about this report visit https://www.researchandmarkets.com/r/bbpqum

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.